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WHEN strain specific tumours are
injected into genetically compatible Fl
hybrid hosts, they often do not grow as
well as in the original parental strain; the
frequency of tumour takes is reduced and
the latent period is prolonged (Snell, 1958;
Hellstrom, 1964) and there is sometimes a
reduction in tumour growth rate. This
inhibitory Fl hybrid effect is most evident
when small tumour inocula are used. We
now report a different type of effect in
which the inoculation of tumour in a
large dose results in accelerated growth in
F1 hybrids.
A poorly differentiated squamous cell
carcinoma was used; it had originated
spontaneously in a female rat of a highly
inbred Wistar subline and had subse-
quently been maintained in this subline by
serial subcutaneous transplantation (Bald-
win, 1966). Its growth was investigated
in Fl hybrids of both sexes resulting from
the cross and reciprocal cross between
this subline and inbred rats of the DA
(Agouti) strain. These hybrids and con-
trol animals of both parental strains were
injected subcutaneously in the flank with
tumour suspension in doses ranging from
1 X 103 to 3-4 x 106 viable cells, this
latter being the highest dose we could
reach with available material. Tumour
cell suspensions had previously been pre-
prepared by mechanical dissociation of
solid tumour from the parental Wistar
strain and had been stored in liquid
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nitrogen with 10% dimethylsulphoxide as
cryopreservative. Before injection, cells
were washed 3 times in Medium 199 and
their viability determined by exclusion of
0-1% trypan blue; then their concentra-
tion was adjusted to give the desired dose.
When tumours appeared, their dimensions
were measured twice weekly until the
animal died, when a complete necropsy
was carried out, noting the extent and
distribution of metastases. Animals
which did not develop tumours were
observed for 2 months after the last
tumour bearing animal in the same group
had died, they were then killed and their
tissues examined both macroscopically
and microscopically for tumour.
The results, summarized in the Table,
show that when tumour was given in
doses of 1 X 106 and 3X4 X 106 cells,
death occurred earlier in Fl hybrids than
in the control parental tumour susceptible
Wistar rats. This earlier death was due
mainly to accelerated growth ofthe estab-
lished tumour, although in most rats
given the highest dose oftumour the latent
period was shortened by 1-2 days. At
the time of death, the size of tumours at
the injection site was approximately the
same in both the hybrids and in sus-
ceptible parental strain controls, but the
hybrids showed more metastases, par-
ticularly in the lungs. Although this
growth acceleration occurred with both
the cross and reciprocal cross, the effectACCELERATED GROWTH OF A RAT TUMOUR
TABLE.-Survival Times in Fl Hybrid and Homozygous Parental Strain Rats Inoculated
with Various Doses of Carcinoma
Cell dose Host
3-4 x 106 Wistar x DA FL
DA x Wistar Fl
Wistar
DA
1 X 106 Wistar x DA Fl
DA x Wistar Fl
Wistar
lx 104 Wistar x DA Fl
DA x Wistar Fl
Wistar
1 X 103 Wistar x DA Fl
DA x Wistar Fl
Wistar
No. of animals
dying of tumour
8/8
8/8
8/8
0/6
8/8
8/8
8/8
8/8
10/11§
8/8
3/8
8/16
12/16
Survival time (days)
MST
27* 9*t
37-8
55-6
33-3T
40-6
42-5
47-5
64-9
57-5
81-3
60-6
68-2
SD Range
3- 2 26-33
6- 8 28-42
28 - 7 30-114
4 0
10-8
6-6
12-4
22-5
27-5
29-7
20-5
18-8
28-41
30-65
35-51
28-69
37-98
29-120
59-115
37--102
34-105
* Significantly different from homozygous Wistar strain at the same dose 0-02 < P < 0 01.
t Significantly different from (DA x Wistar) Fl strains at the same dose 0-002 < P < 0 001.
t Significantly different from homozygous Wistar strain at the same dose 0 005 < P < 0-002.
§ Tumour took in all animals but in one there was complete regression.
was significantly greater when the mother
was of the tumour susceptible Wistar
strain. When the tumour dose was
reduced to 1 x 104 cells the growth rate
was not significantly different from paren-
tal strain rats and when smaller doses than
this were used the usual inhibitory F1
hybrid effect was observed. No tumour
growth was ever observed in the homo-
zygous DA control rats, even with the
highest dose of cells.
Although there is no definite explana-
tion at present for this accelerated tumour
growth in Fl hybrids, immunological
factors could be involved. It may be that
minor antigenic differences existing be-
tween the Fl hybrid and the parental
strain tumour are sufficient to cause a
weak immune response which could, as
Prehn (1972) and Baldwin and Pimm
(1973) suggest, stimulate tumour growth,
perhaps by inflammatory promotion of
blood flow. An alternative explanation
is suggested by a recent report of prefer-
ential tumour growth in Fl hybrid mice:
microcytotoxicity tests demonstrated both
a serum blocking factor and a cellular
immune response against the tumour in
the hybrids, whereas tumour resistant
parental controls showed only the cellular
response (Cotton, Rice and Esber, 1973).
A similar blocking factor might be res-
ponsible for the accelerated growth in our
system.
One curious feature of the accelerated
tumour growth in this system is that it is
much more obvious when the mother of
the hybrid is of the tumour susceptible
strain, suggesting that some factor in the
maternal environment is implicated in the
production of this effect. In this context,
it is interesting to note that the iinhibi-
tory Fl hybrid effect may be much
reduced or even abolished when the
mother of the hybrid is of the tumour
susceptible strain (Oth et al., 1968;
Sanford and Soo, 1971) or when a tumour
susceptible foster mother is used (Oth
et al., 1968).
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